[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dianthus Therapeutics Inc (DNTH)

Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,509,398
  • Shares Outstanding, K 54,666
  • Annual Sales, $ 2,040 K
  • Annual Income, $ -162,340 K
  • EBIT $ -191 M
  • EBITDA $ -197 M
  • 60-Month Beta 1.18
  • Price/Sales 2,198.72
  • Price/Cash Flow N/A
  • Price/Book 3.71

Options Overview Details

View History
  • Implied Volatility 56.80% (-0.54%)
  • Historical Volatility 61.15%
  • IV Percentile 2%
  • IV Rank 1.10%
  • IV High 229.28% on 08/25/25
  • IV Low 54.88% on 12/18/25
  • Expected Move (DTE 27) 4.42 (5.36%)
  • Put/Call Vol Ratio 0.57
  • Today's Volume 47
  • Volume Avg (30-Day) 139
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 10,617
  • Open Int (30-Day) 10,123
  • Expected Range 78.07 to 86.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.93
  • Number of Estimates 5
  • High Estimate $-0.69
  • Low Estimate $-1.23
  • Prior Year $-0.88
  • Growth Rate Est. (year over year) -5.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.85 +19.81%
on 06/10/26
93.61 -11.88%
on 05/29/26
-1.11 (-1.33%)
since 05/18/26
3-Month
68.85 +19.81%
on 06/10/26
96.50 -14.52%
on 04/16/26
+3.63 (+4.60%)
since 03/18/26
52-Week
16.64 +395.88%
on 06/23/25
96.50 -14.52%
on 04/16/26
+65.05 (+372.99%)
since 06/18/25

Most Recent Stories

More News
Stocks Settle Sharply Lower on Escalating Middle East Tensions

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.87%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.98%. June...

ALK : 49.26 (+2.05%)
GOOGL : 368.03 (+1.17%)
MPC : 242.91 (-0.69%)
AAPL : 298.01 (+0.70%)
FDXF : 162.85 (+0.59%)
TSLA : 400.49 (+1.04%)
FANG : 183.50 (-1.07%)
STX : 1,070.23 (+0.39%)
WDC : 746.23 (+4.79%)
AMD : 537.37 (+4.86%)
SPY : 746.74 (+1.04%)
META : 577.22 (+1.70%)
Stocks Resume Decline as Chipmakers and AI Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.80%. June E-mini S&P futures...

ALK : 49.26 (+2.05%)
MPC : 242.91 (-0.69%)
FDXF : 162.85 (+0.59%)
FANG : 183.50 (-1.07%)
WDC : 746.23 (+4.79%)
AMD : 537.37 (+4.86%)
SPY : 746.74 (+1.04%)
ILMN : 161.93 (+1.79%)
SMMT : 13.75 (-2.27%)
MU : 1,133.99 (+8.70%)
AAL : 15.99 (+3.70%)
QQQ : 740.62 (+2.51%)
Stocks Fall on Weakness in Tech and Trucking Companies

The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.28%. June E-mini S&P futures...

SAIA : 435.12 (+2.17%)
ALK : 49.26 (+2.05%)
UAL : 118.32 (+2.15%)
MPC : 242.91 (-0.69%)
AVGO : 411.35 (+4.70%)
CVX : 173.63 (-2.22%)
HNGE : 69.42 (+3.55%)
CBRL : 47.34 (+7.89%)
FDXF : 162.85 (+0.59%)
$IUXX : 30,406.19 (unch)
ARCB : 144.53 (-0.91%)
ZNU26 : 109-105 (-0.27%)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

DNTH : 82.49 (+0.73%)
Dianthus Therapeutics to Participate in Two Investor Conferences

NEW YORK and WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform...

DNTH : 82.49 (+0.73%)
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Early GO decision reached in CAPTIVATE in March 2026 based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A  Claseprubart granted...

DNTH : 82.49 (+0.73%)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform...

DNTH : 82.49 (+0.73%)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

DNTH : 82.49 (+0.73%)
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

NEW YORK and WALTHAM, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus” or the “Company”), a clinical-stage biotechnology company dedicated to developing...

DNTH : 82.49 (+0.73%)
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering

NEW YORK and WALTHAM, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus” or the “Company”), a clinical-stage biotechnology company dedicated to developing...

DNTH : 82.49 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 90.27
2nd Resistance Point 87.64
1st Resistance Point 85.06
Last Price 82.49
1st Support Level 79.85
2nd Support Level 77.22
3rd Support Level 74.64

See More

52-Week High 96.50
Last Price 82.49
Fibonacci 61.8% 65.99
Fibonacci 50% 56.57
Fibonacci 38.2% 47.14
52-Week Low 16.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.